Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

MedWellAI (MWAI) EBIT Margin (2016 - 2025)

MedWellAI (MWAI) has disclosed EBIT Margin for 11 consecutive years, with 49.97% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 17059.0% to 49.97% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 45.32% through Dec 2025, up 2329.0% year-over-year, with the annual reading at 133.44% for FY2025, N/A changed from the prior year.
  • EBIT Margin for Q4 2025 was 49.97% at MedWellAI, up from 339.29% in the prior quarter.
  • The five-year high for EBIT Margin was 1331.92% in Q2 2021, with the low at 51305.23% in Q3 2024.
  • Average EBIT Margin over 5 years is 2674.88%, with a median of 97.32% recorded in 2022.
  • The sharpest move saw EBIT Margin plummeted -5045005bps in 2024, then skyrocketed 5096594bps in 2025.
  • Over 5 years, EBIT Margin stood at 13.03% in 2021, then tumbled by -1166bps to 164.91% in 2022, then soared by 88bps to 19.42% in 2023, then crashed by -1035bps to 220.56% in 2024, then skyrocketed by 77bps to 49.97% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 49.97%, 339.29%, and 1245.09% for Q4 2025, Q3 2025, and Q2 2025 respectively.